EMA initiatives for innovation

Article type: Research Article

Authors: Raymond, Agnes Saint

Affiliations: Scientific Advice, Paediatrics and Orphan Drugs, European Medicines Agency (EMA), London, UK. E-mail: agnes.saint-raymond@ema.europa.eu

Abstract: The strategy for innovation at EMA is defined in the Pharmaceutical Legislation (Reg (EC) No 726/2004). EMA has also outlined a Road Map up to 2010 with two main objectives: to stimulate research and innovation from pharmaceutical and biotechnology enterprises within Europe, and to address hurdles encountered during innovative drug development [1]. In order to support the activities on innovative products, the pharmaceutical legislation offers the definitions and references for innovative medicines.

Keywords: Innovation, pharmaceutical legislation, Road Map, EMA

DOI: 10.3233/PPL-2010-0258

Journal: Pharmaceuticals, Policy and Law, vol. 12, no. 1-2, pp. 15-18, 2010